Generalizability of toxicity data from oncology clinical trials to clinical practice: toxicity of irinotecan-based regimens in patients with metastatic colorectal cancer

Por Tam, V.C., Rask, S., Koru–Sengul, T., Dhesy–Thind, S.
Publicado em 2009

Oncology education in Canadian undergraduate and postgraduate medical programs: a survey of educators and learners

Por Tam, V.C., Berry, S., Hsu, T., North, S., Neville, A., Chan, K., Verma, S.
Publicado em 2014

Oncology education for Canadian internal medicine residents: the value of participating in a medical oncology elective rotation

Por Nixon, N.A., Lim, H., Elser, C., Ko, Y.J., Lee-Ying, R., Tam, V.C.
Publicado no Curr Oncol (2018)

Impact of country-specific EQ-5D-3L tariffs on the economic value of systemic therapies used in the treatment of metastatic pancreatic cancer

Por Lien, K., Tam, V.C., Ko, Y.J., Mittmann, N., Cheung, M.C., Chan, K.K.W.
Publicado no Curr Oncol (2015)

Cost-effectiveness of systemic therapies for metastatic pancreatic cancer

Por Tam, V.C., Ko, Y.J., Mittmann, N., Cheung, M.C., Kumar, K., Hassan, S., Chan, K.K.W.
Publicado em 2013